Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Naloxone and naltrexone. Application in COPD.

S B Reents1, C A Beck

  • 1Ingalls Memorial Hospital, Harvey, Illinois.

Chest
|January 1, 1988
PubMed
Summary

Naloxone and naltrexone, narcotic antagonists, improved breathing in COPD patients when other treatments failed. Abruptly stopping these drugs led to respiratory failure, suggesting their potential as an additional COPD therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of body condition indices reveals different ecotypes of the Antillean manatee.

Scientific reports·2021
Same author

IgG4-specific responses in patients with Staphylococcus aureus bone infections are not predictive of postoperative complications.

European cells & materials·2021
Same author

Deriving a dose and regimen for anti-glucosaminidase antibody passive-immunisation for patients with Staphylococcus aureus osteomyelitis.

European cells & materials·2020
Same author

Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease).

Neurology·2011
Same author

The long march to surrogates of meaningful clinical outcomes in MS trials: are we there yet?

Neurology·2011
Same author

Group patient visits for Parkinson disease: a randomized feasibility trial.

Neurology·2011

Area of Science:

  • Pulmonology
  • Pharmacology

Background:

  • Chronic Obstructive Pulmonary Disease (COPD) presents significant respiratory challenges.
  • Traditional medical therapies for COPD may not be effective in all patients.

Observation:

  • Two patients with severe COPD, unresponsive to conventional treatments, were administered narcotic antagonists (naloxone and naltrexone) as a potential respiratory stimulant.
  • Both patients exhibited notable improvements in respiratory function during the administration of these agents.

Findings:

  • Discontinuation of naloxone and naltrexone resulted in the recurrence of respiratory failure in both patients.
  • This suggests a direct role of narcotic antagonists in supporting respiratory function in these specific COPD cases.

Implications:

  • Narcotic antagonists may represent a novel therapeutic option for select COPD patients.
  • Further research is warranted to explore the efficacy and safety of narcotic antagonists in managing COPD exacerbations.

Related Experiment Videos